Positron Corporation is a leading molecular imaging healthcare company providing innovative technologies and solutions that are reshaping the field of nuclear cardiology. Through our proprietary PET imaging systems, services and radiopharmaceutical solutions, Positron enables healthcare providers to more accurately diagnose disease and improve patient outcomes while practicing cost effective medicine. Positron Corporation provides innovative molecular technologies and services that are reshaping the field of nuclear cardiology through proprietary PET imaging and radiopharmaceutical solutions with a strong commitment to advancing the practice and technology of healthcare. The company was founded in 1983 and has gained significant traction in a diverse industry and continues their strong commitment to excellence and advancing cardiac imaging solutions.
